QTRX
Quanterix CorporationNASDAQHealthcare$3.79+8.91%ClosedMarket Cap: $177.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.57
P/S
1.22
EV/EBITDA
-1.79
DCF Value
$-22.39
FCF Yield
-47.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
46.6%
Operating Margin
-89.9%
Net Margin
-77.2%
ROE
-35.2%
ROA
-25.6%
ROIC
-33.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $43.9M | 45.5% | $-23.9M | $-23.1M | $-0.49 | — |
| FY 2025 | $138.9M | 46.8% | $-87.4M | $-107.2M | $-2.51 | — |
| Q3 2025 | $40.1M | 42.6% | $-37.3M | $-33.5M | $-0.73 | — |
| Q2 2025 | $24.5M | 46.1% | $-37.1M | $-30.0M | $-0.77 | — |
| Q1 2025 | $30.3M | 54.0% | $-26.4M | $-20.5M | $-0.53 | — |
| Q4 2024 | $34.1M | 61.9% | $-14.8M | $-11.6M | $-0.30 | — |
| FY 2024 | $135.4M | 59.9% | $-52.6M | $-38.5M | $-1.00 | — |
| Q3 2024 | $35.4M | 55.8% | $-11.7M | $-8.4M | $-0.22 | — |
| Q2 2024 | $34.1M | 64.4% | $-10.9M | $-7.4M | $-0.25 | — |
| Q1 2024 | $31.8M | 57.5% | $-15.2M | $-11.2M | $-0.26 | — |
| Q4 2023 | $31.2M | 52.7% | $-16.9M | $-12.4M | $-0.33 | — |
| FY 2023 | $121.1M | 60.3% | $-46.0M | $-28.4M | $-0.86 | — |